Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1609163

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1609163

Neurorehabilitation Devices Market by Products (Brain-Computer Interface, Neurorobotics, Noninvasive Stimulators), Therapy Area (Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis) - Global Forecast 2025-2030

PUBLISHED:
PAGES: 199 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

The Neurorehabilitation Devices Market was valued at USD 1.32 billion in 2023, expected to reach USD 1.42 billion in 2024, and is projected to grow at a CAGR of 7.62%, to USD 2.22 billion by 2030.

The neurorehabilitation devices market encompasses technology and equipment designed to aid in the recovery, enhancement, and maintenance of neurological function. This scope includes robotics, brain-computer interfaces, non-invasive brain stimulators, and wearable devices aimed at assisting patients in recovery from neurological conditions like stroke, traumatic brain injuries, and Parkinson's disease. The necessity for neurorehabilitation is rising due to increasing incidences of neurological disorders, an aging population, and greater awareness of innovative treatment approaches. This equipment is applied across hospitals, clinics, and home settings, providing therapy and monitoring for patients with varied neurological impairment levels. Healthcare providers, patients, and even insurance companies are primary end-users, leveraging these devices for improved outcomes in mobility, speech, and motor skill rehabilitation.

KEY MARKET STATISTICS
Base Year [2023] USD 1.32 billion
Estimated Year [2024] USD 1.42 billion
Forecast Year [2030] USD 2.22 billion
CAGR (%) 7.62%

Key growth factors influencing this market include technological advancements, such as AI and IoT integration, increasing healthcare expenditure, and supportive government initiatives for neurological research. Potential opportunities lie in emerging markets, where demand is growing for advanced medical solutions, and telemedicine integration, allowing remote monitoring and therapy solutions. Recommendations to seize these opportunities include targeting unpenetrated geographic regions, developing affordable yet advanced devices, and forming strategic partnerships with healthcare providers to enhance market reach.

However, the market faces limitations, such as high device costs, lengthy approval processes, and the need for better-trained professionals to administer these technologies effectively. These challenges are compounded by stringent regulatory environments and the technological maturity required for effective deployment.

Areas ripe for innovation include AI-driven personalized rehabilitation programs, machine learning-based diagnostics, and the development of more user-friendly and accessible devices. Research efforts could be directed towards enhancing device portability and reducing costs to expand patient reach. The neurorehabilitation devices market is dynamic, characterized by rapid technological advancements and an increasing emphasis on patient-centered care, offering significant potential for growth and innovation.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neurorehabilitation Devices Market

The Neurorehabilitation Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of neurological disorders such as brain injuries and stroke
    • Growing awareness among patients and healthcare providers
    • Rising geriatric population globally
  • Market Restraints
    • Relatively expensive rehabilitation services
  • Market Opportunities
    • Development of new technologies in electrostimulation coupled with research and development activities
    • Emerging availability of wearable devices with penetration of digitization
  • Market Challenges
    • Lack of adequate number of rehabilitation centers compared to the number of patients

Porter's Five Forces: A Strategic Tool for Navigating the Neurorehabilitation Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neurorehabilitation Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neurorehabilitation Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neurorehabilitation Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neurorehabilitation Devices Market

A detailed market share analysis in the Neurorehabilitation Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neurorehabilitation Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neurorehabilitation Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neurorehabilitation Devices Market

A strategic analysis of the Neurorehabilitation Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neurorehabilitation Devices Market, highlighting leading vendors and their innovative profiles. These include AlterG, Inc., Biometrics Ltd., Bioness Inc. by Bioventus Inc., Bionik Laboratories Corp., BioXtreme Ltd., Ekso Bionics Holdings, Inc., Eodyne Systems, SL, Hocoma AG by DIH Medical, Kinestica d.o.o., MediTouch Ltd., Medtronic PLC, Neofect, Neuro Rehab VR, Reha Technology AG, and Rehab-Robotics Company Limited.

Market Segmentation & Coverage

This research report categorizes the Neurorehabilitation Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Products, market is studied across Brain-Computer Interface, Neurorobotics, Noninvasive Stimulators, and Wearable Devices.
  • Based on Therapy Area, market is studied across Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis, Parkinson's Disease, and Stroke.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-710B1F0AC5A5

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of neurological disorders such as brain injuries and stroke
      • 5.1.1.2. Growing awareness among patients and healthcare providers
      • 5.1.1.3. Rising geriatric population globally
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively expensive rehabilitation services
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of new technologies in electrostimulation coupled with research and development activities
      • 5.1.3.2. Emerging availability of wearable devices with penetration of digitization
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of adequate number of rehabilitation centers compared to the number of patients
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Neurorehabilitation Devices Market, by Products

  • 6.1. Introduction
  • 6.2. Brain-Computer Interface
  • 6.3. Neurorobotics
  • 6.4. Noninvasive Stimulators
  • 6.5. Wearable Devices

7. Neurorehabilitation Devices Market, by Therapy Area

  • 7.1. Introduction
  • 7.2. Brain & Spinal Cord Injury
  • 7.3. Cerebral Palsy
  • 7.4. Multiple Sclerosis
  • 7.5. Parkinson's Disease
  • 7.6. Stroke

8. Americas Neurorehabilitation Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Neurorehabilitation Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Neurorehabilitation Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AlterG, Inc.
  • 2. Biometrics Ltd.
  • 3. Bioness Inc. by Bioventus Inc.
  • 4. Bionik Laboratories Corp.
  • 5. BioXtreme Ltd.
  • 6. Ekso Bionics Holdings, Inc.
  • 7. Eodyne Systems, SL
  • 8. Hocoma AG by DIH Medical
  • 9. Kinestica d.o.o.
  • 10. MediTouch Ltd.
  • 11. Medtronic PLC
  • 12. Neofect
  • 13. Neuro Rehab VR
  • 14. Reha Technology AG
  • 15. Rehab-Robotics Company Limited
Product Code: MRR-710B1F0AC5A5

LIST OF FIGURES

  • FIGURE 1. NEUROREHABILITATION DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROREHABILITATION DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES NEUROREHABILITATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES NEUROREHABILITATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. NEUROREHABILITATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. NEUROREHABILITATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEUROREHABILITATION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEUROREHABILITATION DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY BRAIN-COMPUTER INTERFACE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY NEUROROBOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY NONINVASIVE STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY BRAIN & SPINAL CORD INJURY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY CEREBRAL PALSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEUROREHABILITATION DEVICES MARKET SIZE, BY STROKE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES NEUROREHABILITATION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM NEUROREHABILITATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM NEUROREHABILITATION DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 104. NEUROREHABILITATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. NEUROREHABILITATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!